CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-29 | ORBIMED ADVISORS LLC 10% owner | Purchase | +50,000 | $14.99 | $750K | 3,022,760 |
| 2018-01-26 | ORBIMED ADVISORS LLC 10% owner | Purchase | +22,760 | $14.93 | $340K | 2,972,760 |
| 2018-01-24 | ORBIMED ADVISORS LLC 10% owner | Purchase | +64,637 | $14.91 | $964K | 2,950,000 |
| 2018-01-23 | ORBIMED ADVISORS LLC 10% owner | Purchase | +4,363 | $14.99 | $65K | 2,885,363 |
| 2018-01-22 | ORBIMED ADVISORS LLC 10% owner | Purchase | +75,000 | $14.98 | $1.1M | 2,881,000 |
| 2018-01-19 | ORBIMED ADVISORS LLC 10% owner | Purchase | +74,931 | $14.95 | $1.1M | 2,806,000 |
| 2018-01-12 | ORBIMED ADVISORS LLC 10% owner | Purchase | +38,354 | $14.50 | $556K | 2,731,069 |
| 2018-01-12 | ORBIMED ADVISORS LLC 10% owner | Purchase | +28,446 | $15.40 | $438K | 2,692,715 |
| 2018-01-11 | ORBIMED ADVISORS LLC 10% owner | Purchase | +41,700 | $13.65 | $569K | 2,664,269 |
| 2018-01-10 | ORBIMED ADVISORS LLC 10% owner | Purchase | +170,338 | $12.83 | $2.2M | 2,622,569 |
| 2017-11-20 | Bazemore Todd Chief Operating Officer | Grant or award · Stock Option (right to buy) | +172,000 | $19.60 | $3.4M | 172,000 |
| 2017-09-28 | KOVEN ANDREW I Director | Grant or award · Stock Option (right to buy) | +25,920 | 25,920 | ||
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +36,094 | $0.68 | $25K | 36,094 |
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +16,168 | $0.68 | $11K | 52,262 |
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +44,313 | $2.30 | $102K | 96,575 |
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +12,150 | $3.34 | $41K | 108,725 |
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −36,094 | 0 | ||
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −16,168 | 1,880 | ||
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −44,313 | 18,247 | ||
| 2017-08-11 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −12,150 | 149,985 |
Page 21 of 24 · 472 trades